Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
about
Emerging critical role of molecular testing in diagnostic genitourinary pathologyResolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cellsThe current state of preclinical prostate cancer animal models.Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcriptsThe evolving biology and treatment of prostate cancer.Behavioral stress accelerates prostate cancer development in mice.Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implicationsImpaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway.Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targetsPrognostic determinants in prostate cancer.Diagnostic and prognostic molecular biomarkers for prostate cancer.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionPrognostic prostate tissue biomarkers of potential clinical use.Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.New roles of G protein-coupled receptor kinase 2 (GRK2) in cell migration.Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model.Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathwayGrowth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.MYC overexpression at the protein and mRNA level and cancer outcomes among men treated with radical prostatectomy for prostate cancer.Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism.Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature
P2860
Q27021371-E2B629C4-CEB2-4F2B-90BA-3914457AAEEDQ27324165-1037E21C-1340-491D-9A40-74778D7A58A0Q30418797-273E4D16-FE06-4DC2-821E-5A52CE3B7AC5Q33755486-295C022F-0FF8-4EC9-A378-C416ED1C8D13Q35951473-4B0C8E96-1120-4099-9212-26172723D75CQ36580367-E911DD6F-15DA-49AD-AFD3-3ACAC42D5D7EQ36892504-83C0C700-FBC2-45AB-96AC-C1CC0A976172Q36959063-64E37CBE-909F-4192-9D08-9A939909ABCAQ37445062-3AD4FD57-B2C4-43C4-8503-FC4750F9B26DQ37768803-11F2B0E5-B08D-4B9A-AFC6-42BD53926F27Q37966912-002C356E-03D2-4BAB-80D0-A8BF028BE346Q37972703-A68B1127-6DE4-4102-B68C-2CB273E3BC33Q38108308-0EBF63AD-9EEB-4825-B1BB-6677EC94CF1BQ38184382-C63A2FF1-ECDA-48F2-8920-1D6ED9CB0CD1Q38838867-46659C81-FA64-4C97-BEDE-20E367526BAAQ39859981-8D2C5607-96FF-4486-9E1A-70F81D5F08DDQ39903504-47598963-500A-48D8-B1B8-31B796DF62F9Q40634245-B6B056A0-79FE-4B37-813F-EB4C2A68DD30Q41084236-78583876-803F-4A66-9C36-5E36BF3EFF48Q41903711-CA450011-16C5-460A-911A-373352932BA6Q42444695-BC2D0ED8-AF4A-4E0A-B675-3D93BE722E6FQ47399099-107F92FF-7E42-4EE9-8547-A0F2C96DD3B6Q48240280-0688EFED-5F96-421C-989E-05F73003CFDFQ53376173-BB408E60-BC37-44D9-A4A5-7014E03D11FAQ57073785-55A6D595-8579-4A3C-BA85-0DD069EB7FD2
P2860
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
@ast
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
@en
type
label
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
@ast
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
@en
prefLabel
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
@ast
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
@en
P2093
P2860
P356
P1476
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays
@en
P2093
I Prowatke
P2860
P2888
P356
10.1038/SJ.BJC.6603490
P407
P577
2006-12-05T00:00:00Z